SCHEMBL1723959

SCHEMBL1723959

CC(=O)c1cccc(C(C)=O)[n+]1Cc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
ALDH1A1 P00352 2/20 0.42
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MAOB P27338 2/20 0.39
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
AKR1B1 P15121 1/20 0.39
TP53 P04637 1/20 0.38
ALPI P09923 1/20 0.37
PKM P14618 1/20 0.37
PTGS1 P23219 1/20 0.37
XIAP P98170 1/20 0.37
SLC7A5 Q01650 1/20 0.37
AMPD2 Q01433 1/20 0.36
KEAP1 Q14145 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12201250 0.92 CYP2D6 (0.39) LMNACYP2D6CYP2C19L3MBTL1ALDH1A1
SCHEMBL1723479 0.78 CYP2D6 (0.66) LMNACYP2D6CYP2C19L3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL1712098 0.77 CYP2D6 (0.64) LMNACYP2D6CYP2C19L3MBTL1ALDH1A1
Bromide SCHEMBL1712889 0.77 CYP2D6 (0.64) LMNACYP2D6CYP2C19L3MBTL1ALDH1A1
SCHEMBL1724177 0.75 THRB (0.38) LMNAALDH1A1TSHRSMN1; SMN2CES2
Acetic Acid SCHEMBL1712555 0.74 CYP2D6 (0.60) LMNACYP2D6CYP2C19L3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL11604018 0.73 CYP2D6 (0.59) LMNACYP2D6CYP2C19L3MBTL1ALDH1A1
SCHEMBL1724231 0.72 THRB (0.35) LMNACYP2D6ALDH1A1TSHRNPSR1
Sulfuric Acid SCHEMBL2183925 0.71 CYP2D6 (0.56) LMNACYP2D6CYP2C19L3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL1712399 0.71 THRB (0.34) ALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2320854-B1 BLEACHING AGENT COMPRISING 2-ACYLPYRIDINIUM DERIVATIVES HENKEL AG & CO KGAA (DE) 2012-01-18 EP disclosed
EP-2320854-B1 BLEACHING AGENT COMPRISING 2-ACYLPYRIDINIUM DERIVATIVES HENKEL AG & CO KGAA (DE) 2012-01-18 EP disclosed
US-20110162671-A1 BLEACHING AGENT COMPRISING 2-ACYLPYRIDINIUM DERIVATIVES HENKEL AG & CO. KGAA (DE) 2011-07-07 US disclosed
WO-2010054981-A2 COMBINATION OF CATIONIC BLEACH ACTIVATORS AND DYES HENKEL AG & CO. KGAA (DE) 2010-05-20 WO disclosed
WO-2010029006-A2 BLEACHING AGENT COMPRISING 2-ACYLPYRIDINIUM DERIVATIVES HENKEL AG & CO. KGAA (DE) 2010-03-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110162671-A1 BLEACHING AGENT COMPRISING 2-ACYLPYRIDINIUM DERIVATIVES KRT18, CBR3, ACOX3 LMNA 631/4885CYP2D6 758/4885CYP2C19 1434/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.